Cerenome, Inc. SEC filings CNSY
Cerenome, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 14, 2011. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 31, 2026 | — |
| DEF 14A | Proxy statement | Mar 31, 2026 | May 14, 2026 |
| DEFA14A | Additional proxy material | Aug 1, 2025 | — |
| DEF 14A | Proxy statement | Jul 21, 2025 | Aug 7, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 11, 2025 | Aug 7, 2025 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 2, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2025 | Mar 14, 2025 |
| DEFA14A | Additional proxy material | Jul 12, 2024 | — |
| DEF 14A | Proxy statement | Jul 10, 2024 | Aug 15, 2024 |
| DEF 14A | Proxy statement | Mar 7, 2023 | Apr 20, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2023 | Apr 20, 2023 |
| DEFA14A | Additional proxy material | Apr 7, 2022 | — |
| DEF 14A | Proxy statement | Apr 7, 2022 | May 16, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2022 | Mar 28, 2022 |
| DEFA14A | Additional proxy material | Apr 5, 2021 | — |
| DEF 14A | Proxy statement | Apr 5, 2021 | May 17, 2021 |
| DEF 14A | Proxy statement | May 13, 2020 | Jun 16, 2020 |
| PRE 14A | Preliminary proxy statement | May 1, 2020 | May 1, 2020 |
| DEF 14A | Proxy statement | Apr 19, 2019 | May 28, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2019 | May 28, 2019 |
| DEF 14A | Proxy statement | Apr 6, 2018 | May 18, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 26, 2018 | May 18, 2018 |
| DEF 14A | Proxy statement | Apr 10, 2017 | May 22, 2017 |
| DEF 14A | Proxy statement | Mar 15, 2016 | Mar 15, 2016 |
| PRE 14A | Preliminary proxy statement | Mar 3, 2016 | Mar 3, 2016 |
| DEF 14A | Proxy statement | Jul 2, 2015 | Jul 2, 2015 |
| PRE 14A | Preliminary proxy statement | Jun 22, 2015 | Jun 22, 2015 |
| DEF 14A | Proxy statement | Nov 24, 2014 | Jan 6, 2015 |
| PRE 14A | Preliminary proxy statement | Nov 14, 2014 | Nov 13, 2014 |
| DEF 14A | Proxy statement | Jun 12, 2014 | Jul 31, 2014 |
| DEF 14A | Proxy statement | Jul 19, 2013 | Aug 28, 2013 |
| PRE 14A | Preliminary proxy statement | Jul 9, 2013 | Aug 28, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2012 | Aug 16, 2012 |
| DEF 14A | Proxy statement | May 2, 2011 | Aug 16, 2011 |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- CNSY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1095981
- Former names
- PLUS THERAPEUTICS, INC. (until Jul 1, 2026); CYTORI THERAPEUTICS, INC. (until Aug 2, 2019); MACROPORE INC (until Jul 5, 2005)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.